Ryoji Hanada

Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group

Ichiro Tsukimoto, Akio Tawa, Keizo Horibe et al. · Journal of Clinical Oncology · 2009 · 233 citations · Full text

Spontaneous regression of localized neuroblastoma detected by mass screening.

Keiko Yamamoto, Ryoji Hanada, Akira Kikuchi et al. · Journal of Clinical Oncology · 1998 · 221 citations

Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children

Seiji Kojima, Akira Ohara, Masahiro Tsuchida et al. · Blood · 2002 · 192 citations · Full text

Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1

Yasuhide Hayashi, Naotoshi Kanda, Toshiya Inaba et al. · Cancer · 1989 · 184 citations

Pediatric Brain Tumors, Cytogenetics, Pathology +18

Tandem duplication of the <i>FLT3</i> gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children

Feng Xu, Tomohiko Taki, Hong Yang et al. · British Journal of Haematology · 1999 · 177 citations

Mixed-phenotype Acute Leukemia, Genetics, Pathology +16